Remodeling a DNA-binding protein as a specific in vivo inhibitor of bacterial secretin PulD.

Archive ouverte

Mouratou, B. | Schaeffer, F. | Guilvout, I. | Tello-Manigne, D. | Pugsley, Anthony Paul | Alzari, Pedro Maria | Pecorari, F.

Edité par CCSD ; National Academy of Sciences -

International audience. We engineered a class of proteins that binds selected polypeptides with high specificity and affinity. Use of the protein scaffold of Sac7d, belonging to a protein family that binds various ligands, overcomes limitations inherent in the use of antibodies as intracellular inhibitors: it lacks disulfide bridges, is small and stable, and can be produced in large amounts. An in vitro combinatorial/selection approach generated specific, high-affinity (up to 140 pM) binders against bacterial outer membrane secretin PulD. When exported to the Escherichia coli periplasm, they inhibited PulD oligomerization, thereby blocking the type II secretion pathway of which PulD is part. Thus, high-affinity inhibitors of protein function can be derived from Sac7d and can be exported to, and function in, a cell compartment other than that in which they are produced.

Consulter en ligne

Suggestions

Du même auteur

Artificial binding proteins (Affitins) as probes for conformational changes in secretin PulD.

Archive ouverte | Krehenbrink, M. | CCSD

International audience. The DNA-binding protein Sac7d was previously modified to bind with high affinity to the N domain of the outer membrane secretin PulD from the bacterium Klebsiella oxytoca. Here, we show that ...

Secretins take shape

Archive ouverte | Bayan, Nicolas | CCSD

International audience. Secretins are a unique class of bacterial multimeric outer membrane proteins that probably differ considerably from other, less complex outer membrane proteins in their overall structure and ...

Towards Improved Peptidic α‐Ketoamide Inhibitors of the Plasmodial Subtilisin‐Like SUB1: Exploration of N‐Terminal Extensions and Cyclic Constraints

Archive ouverte | Puszko, Anna | CCSD

International audience. After more than 15 years of decline, the Malaria epidemy has increased again since 2017, reinforcing the need to identify drug candidates active on new targets involved in at least two biolog...

Chargement des enrichissements...